论文信息 - First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis - 字舞流文

First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis

J. Bassaganya-Riera | R. Hontecillas | Nuria Tubau-Juni | A. Leber | Panita Maturavongsadit | J. Chauhan